EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Nomogram for Predicting Cardiac Death and Heart Transplantation in Arrhythmogenic Right Ventricular Cardiomyopathy

Yiju Luo iD, Xin Chen, Yuhua Zhang, Qianhuan Zhang, Fangzhou Liu, Guanhao Luo, Shulin Wu, Yumei Xue, Hai Deng, Fengyu Jiang, Zien Chen, Yang Liu and 1 more

ESC Heart Failure · 2023

DOI: 10.1002/ehf2.14432 ↗

At a glance

Journal article in ESC Heart Failure, 2023. Written by Yiju Luo and 12 co-authors. Institution: Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. Major MEDLINE topics: Arrhythmogenic Right Ventricular Dysplasia, Nomograms, Heart Transplantation, Death, Sudden, Cardiac. Cited 1 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Science and Technology Programs of Guangdong Province, National Natural Science Foundation of China, Zhongnanshan Medical Foundation of Guangdong Province.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Aims

In this study, we aimed to develop and validate a competing risk nomogram for predicting cardiac death and heart transplantation (HT) in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC).

Methods

We retrospectively enrolled 149 consecutive patients with ARVC diagnosed at our institution between 2008 and 2022. Cox proportional hazards model was primarily used to identify variables associated with cardiac death and HT. On the basis of these indicators, a competing risk nomogram was developed to predict the 1, 3, and 5 year probabilities of cardiac death and HT. The area under the receiver operating characteristic curve (AUC), Harrell's C-index, and calibration curves were used to evaluate and internally validate the performance of the model. Decision curve analysis was performed to assess the clinical utility of the nomogram.

Result

Of the 149 patients with ARVC, the mean age was 38.77 ± 15.94 years, and most of the patients were men (67.11%, 100/149). Fourteen patients experienced cardiac death and nine underwent HT, during a median follow-up period of 5.8 years (interquartile range, 0.62–5.56 years). Multivariable COX analysis revealed that extent of TWI in the anterior and inferior leads (P = 0.0057), right atrial diameter on transthoracic echocardiography (P = 0.0498), RVEF (P = 0.1036), and LVEF (P < 0.001) all showed statistical significance. The 1-, 3-, and 5-year cumulative incidence of cardiac death and HT were 3.35%, 8.05%, and 11.4%, respectively. The area under the receiver operating characteristic curve of the nomogram for predicting cardiac death and HT at 1, 3, and 5 years after diagnosis of ARVC were 0.860, 0.935, and 0.956. The value of Harrell's C-index is 0.9273 (95% confidence interval 0.8954–0.9590; P < 0.001), indicating that the model had good discriminative ability in internal validation. Decision curve analysis revealed that our model was clinically useful within the entire range of potential treatment thresholds in most cases. The cumulative incidence of the primary outcomes was significantly different between the three risk groups according to nomogram-derived scores (P < 0.001).

Conclusions

On the basis of a retrospective review of patients with ARVC at a single centre, we developed a novel nomogram for predicting the risk of cardiac death and HT after ARVC diagnosis. This competing risk nomogram based on four readily available clinical parameters (right atrial diameter, right and left ventricular ejection fraction, and T-wave inversion) is a potentially useful tool for individualized prognostic assessment in patients with ARVC.

Subjects

MeSH terms (MEDLINE)

Arrhythmogenic Right Ventricular DysplasiaNomogramsHeart TransplantationDeath, Sudden, CardiacHumansMaleFemaleRetrospective StudiesAdultRisk AssessmentMiddle AgedFollow-Up StudiesROC CurvePrognosisSurvival RateRisk Factors

Author keywords

Arrhythmogenic right ventricular cardiomyopathyCardiac death and heart transplantationNomogram

Authors and institutions

  • Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

ORCID profiles: Yiju Luo

Funding

  • Science and Technology Programs of Guangdong Province
  • National Natural Science Foundation of China
  • Zhongnanshan Medical Foundation of Guangdong Province

Cite

APA

Luo, Y., Chen, X., Zhang, Y., Zhang, Q., Liu, F., Luo, G., Wu, S., Xue, Y., Deng, H., Jiang, F., Chen, Z., Liu, Y., & Liao, H. (2023). Nomogram for Predicting Cardiac Death and Heart Transplantation in Arrhythmogenic Right Ventricular Cardiomyopathy. ESC Heart Failure. https://doi.org/10.1002/ehf2.14432

Vancouver

Luo Y, Chen X, Zhang Y, Zhang Q, Liu F, Luo G, et al. Nomogram for Predicting Cardiac Death and Heart Transplantation in Arrhythmogenic Right Ventricular Cardiomyopathy. ESC Heart Failure. 2023. doi:10.1002/ehf2.14432

BibTeX
@article{Luo2023,
  author = {Luo, Yiju and Chen, Xin and Zhang, Yuhua and Zhang, Qianhuan and Liu, Fangzhou and Luo, Guanhao and Wu, Shulin and Xue, Yumei and Deng, Hai and Jiang, Fengyu and Chen, Zien and Liu, Yang and Liao, Hongtao},
  title = {Nomogram for Predicting Cardiac Death and Heart Transplantation in Arrhythmogenic Right Ventricular Cardiomyopathy},
  journal = {ESC Heart Failure},
  year = {2023},
  doi = {10.1002/ehf2.14432}
}
Start for free →